Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2008
02/05/2008US7326403 That can selectively accumulate in tumor cells or tumor tissue for use as a scintillation imaging agent; 1-alkyl-2-((3-alkyl-5-(3-(iodophenylalkyl)benzothiazolin-2-yliden)-4-oxothiazolidin-2-ylidene)methyl)pyridinium p-toluenesulfonate
02/05/2008CA2205406C Novel benzyl pyrimidines
01/2008
01/31/2008WO2008012524A1 Substituted aniline derivatives
01/31/2008WO2008012027A1 Insecticidal compounds
01/31/2008WO2007120574A3 Diaryl substituted alkanes
01/31/2008WO2007098507A3 Compositions and methods for inhibition of the jak pathway
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027219 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation
01/31/2008US20080027076 Pyrimidines With Tie2 (Tek) Activity
01/31/2008US20080027058 Mitotic Kinesin Inhibitors
01/31/2008US20080027054 4-Substituted quinolines as antitumor agents
01/31/2008US20080027047 Compounds that modulate HSP90 activity and methods for identifying same
01/31/2008US20080027038 N-Acylated lipophilic amino acid derivatives
01/31/2008US20080025916 Tailored Treatment Suitable for Different Forms of Mastocytosis
01/31/2008CA2658913A1 Substituted aniline derivatives
01/30/2008EP1882690A2 A process for the preparation of epothilone analogs and intermediates
01/30/2008EP1882474A1 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism
01/30/2008EP1881978A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
01/30/2008EP1881977A1 Histone deacetylase inhibitors
01/30/2008EP1881976A1 Substituted amide derivatives as protein kinase inhibitors
01/30/2008EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
01/30/2008EP1881966A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
01/30/2008EP1881830A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
01/30/2008EP1881827A1 Fused thiazole derivatives as kinase inhibitors
01/30/2008CN101115750A Water-soluble tetrazolium salts
01/30/2008CN101115742A Heterocycle derivatives as histone deacetylase (hdac) inhibitors
01/30/2008CN101115741A 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
01/30/2008CN101115734A Spiro derivatives as lipoxygenase inhibitors
01/30/2008CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands
01/30/2008CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
01/30/2008CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors
01/29/2008US7323573 Production of polyketides
01/29/2008US7323482 Therapy of p38 kinase-associated conditions; may be useful in treating inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
01/29/2008US7323481 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
01/29/2008US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient
01/29/2008US7323455 1,2,3,5-Tetrahydro-4,1-benzoxazepine derivatives: 4-methyl-5-(5-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4,1-benzoxazepin-7-yl)thiophene-2-carbonitrile; contraceptives; hormone replacement therapy
01/29/2008CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids
01/29/2008CA2255620C Novel anandamide amidase inhibitors as analgesic agents
01/24/2008WO2008011190A1 Cgrp receptor antagonists
01/24/2008WO2008010921A2 Modulators of pharmacokinetic properties of therapeutics
01/24/2008WO2008010433A1 Bridged cyanine compounds and optical recording materials containing the same
01/24/2008WO2008009487A1 Heterobicyclic carboxamides as inhibitors for kinases
01/24/2008WO2008009435A1 Amino-piperidine derivatives as cetp inhibitors
01/24/2008WO2008009406A1 Novel pyridazine derivatives
01/24/2008WO2008009405A2 Novel pyridazine derivatives
01/24/2008WO2008009210A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases
01/24/2008WO2008009209A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases
01/24/2008WO2007140439A3 Compounds as cannabinoid receptor ligands and uses thereof
01/24/2008WO2007137417B1 Heterocyclic compounds as calcium channel blockers
01/24/2008WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
01/24/2008WO2007130075A8 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
01/24/2008WO2007128086A3 Novel viral replication inhibitor
01/24/2008US20080021217 Heterocyclic inhibitors of rho kinase
01/24/2008US20080021215 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation; antibacterial agent
01/24/2008US20080021214 Novel process for the preparation of linezolid and related compounds
01/24/2008US20080021213 Intermediates for oxazolidinone antibacterials; N-[3-Chloro-2-(R)-hydroxypropyl]-3-fluoro-4-morpholinyl aniline
01/24/2008US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay
01/24/2008US20080021052 Novel glucokinase activators and methods of using same
01/24/2008US20080021025 Inhibitors of cathepsin s
01/24/2008US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity
01/24/2008US20080021010 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction
01/24/2008US20080021009 1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
01/24/2008CA2658573A1 Cgrp receptor antagonists
01/24/2008CA2658254A1 Novel pyridazine derivatives
01/24/2008CA2657936A1 Antiviral protease inhibitors
01/24/2008CA2657850A1 Novel pyridazine derivatives
01/24/2008CA2657258A1 Amino-piperidine derivatives as cetp inhibitors
01/24/2008CA2653374A1 Modulators of pharmacokinetic properties of therapeutics
01/24/2008CA2645189A1 Process for preparation of intermediates of rosiglitazone, rosiglitazone and new polymorphic forms thereof
01/24/2008CA2644047A1 Heterobicyclic carboxamides as inhibitors for kinases
01/23/2008EP1880995A1 Method for producing indole derivative having piperidine ring
01/23/2008EP1879887A2 Npy antagonists, preparation and use
01/23/2008EP1879886A1 Mitotic kinesin inhibitors and methods of use thereof
01/23/2008EP1879885A1 Heterocyclic antiviral compounds
01/23/2008EP1879882A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
01/23/2008EP1879878A2 New heterocyclylethylcarboxamide derivatives
01/23/2008EP1879580A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
01/23/2008EP1879574A2 Multimediator 5-ht6 receptor antagonists, and uses related thereto
01/23/2008EP1879563A2 Novel chemical compounds
01/23/2008EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
01/23/2008EP1711825A4 Conjugated small molecules
01/23/2008EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
01/23/2008EP1636215B1 Furazanobenzimidazoles
01/23/2008EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
01/23/2008EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
01/23/2008EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
01/23/2008EP1322619B1 Isoquinolinone potassium channel inhibitors
01/23/2008EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
01/23/2008CN101111489A Amino-pyridines as inhibitors of beta-secretase
01/23/2008CN101111486A 抗糖尿病二环化合物 Antidiabetic bicyclic compound
01/23/2008CN101111484A Process for the manufacture of a precursor of vitamin b*
01/23/2008CN101111479A Pyridones used as inhibitors of kinases
01/23/2008CN101111250A Substituted 5-phenyl pyrimidines i in therapy
01/23/2008CN101108830A Cyclic compound, process for producing the same, and pest control agent
01/23/2008CN100363458C White electroluminescent polymer material and its preparing method
01/23/2008CN100363362C Thiazole derivatives as NPY receptor antagonists
01/23/2008CN100363361C Hetaryl-substd. heterocycles
01/23/2008CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases
01/22/2008US7321063 Sulfonamide inhibitors of aspartyl protease
01/22/2008US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole